ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA

Clinical trials for ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA explained in plain language.

Never miss a new study

Get alerted when new ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA trials appear

Sign up with your email to follow new studies for ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New transplant approach aims to tame bone marrow failure

Disease control Recruiting now

This phase 2 trial tests a bone marrow transplant using lower doses of chemotherapy and radiation to prepare the body, along with a drug called cyclophosphamide after transplant to prevent graft-versus-host disease. It enrolls 60 people with severe aplastic anemia or related bone…

Matched conditions: ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA

Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA

Get alerted when new ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA trials appear

New transplant approach aims to tame bone marrow failure